An emerging treatment for clinical depression has reached an important milestone. This week, the Food and Drug Administration ...

The announcement was welcome news for those with major depressive disorder, affecting an estimated 8.3% of the adult ...

The U.S. Food and Drug Administration expanded approval for Johnson & Johnson's nasal spray, Spravato, to allow it to be used ...

Respondents who said they used other drugs recreationally were also likelier to say they used ketamine during the past year ...

A multidisciplinary approach, including ketamine withdrawal and symptom management, is essential to mitigate long-term ...

Here's what MDs want you to know about Spravato, the latest FDA-approved standalone nasal spray for depression.

Ketamine, the controlled drug best known as a horse tranquilizer or party supplement, has in the last four years become a ...

"Treatment-resistant depression can be very complicated, especially for patients who do not respond to oral antidepressants ...

Effective treatments for people with serious depression who have not been helped by antidepressant medications have novel ...

Those who said they used other drugs were likelier to report ketamine use as well, Yang says. Participants with depression were likelier to report ketamine use than those without depression ...